308 related articles for article (PubMed ID: 16644899)
1. Role of matrix metalloproteinases in intestinal inflammation.
Medina C; Radomski MW
J Pharmacol Exp Ther; 2006 Sep; 318(3):933-8. PubMed ID: 16644899
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
De S; Fenton JE; Jones AS
J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain.
Dzwonek J; Rylski M; Kaczmarek L
FEBS Lett; 2004 Jun; 567(1):129-35. PubMed ID: 15165905
[TBL] [Abstract][Full Text] [Related]
5. TIMPs as multifacial proteins.
Lambert E; Dassé E; Haye B; Petitfrère E
Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
[TBL] [Abstract][Full Text] [Related]
6. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
[TBL] [Abstract][Full Text] [Related]
7. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
[TBL] [Abstract][Full Text] [Related]
9. The role of matrix metalloproteinases in the oral environment.
Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
[TBL] [Abstract][Full Text] [Related]
10. Role of matrix metalloproteinases in inflammatory bowel disease.
Naito Y; Yoshikawa T
Mol Aspects Med; 2005; 26(4-5):379-90. PubMed ID: 16112187
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
12. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
13. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
Mannello F
Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
[TBL] [Abstract][Full Text] [Related]
14. [The MMP/TIMP system in the nervous system].
Rivera S; Jourquin J; Ogier C; Bernard A; Charton G; Tremblay E; Khrestchatisky M
Med Sci (Paris); 2004 Jan; 20(1):55-60. PubMed ID: 14770364
[TBL] [Abstract][Full Text] [Related]
15. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
16. Effect of tissue inhibitors of metalloproteinases and matrix metalloproteinases on capsular formation around smooth and textured silicone gel implants.
Ulrich D; Ulrich F; Pallua N; Eisenmann-Klein M
Aesthetic Plast Surg; 2009 Jul; 33(4):555-62. PubMed ID: 19330370
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease.
Altadill A; Eiró N; González LO; Junquera S; González-Quintana JM; Sánchez MR; Andicoechea A; Saro C; Rodrigo L; Vizoso FJ
Inflamm Bowel Dis; 2012 Jan; 18(1):120-30. PubMed ID: 21438097
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
Maskos K
Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
[TBL] [Abstract][Full Text] [Related]
20. The involvement of metalloproteinases and their tissular inhibitors in the processes of periodontal orthodontic remodeling.
Surlin P; Rauten AM; Mateescu GO; Oprea B; Mariş M; Manolea H
Rom J Morphol Embryol; 2009; 50(2):181-4. PubMed ID: 19434308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
